Indication: Pulmonary Arterial Hypertension
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension (ADVANCE-extension)
Sub-indication: Pulmonary Arterial Hypertension (PAH)
Study Type: Drug Study
Principal Investigator: John McConnell, M.D.Norton Pulmonary Specialists
Sponsor: Sponsor: UNITED THERAPEUTICS CORPORATION
Learn more at ClinicalTrials.gov
Email for more information: npsresearch@nortonhealthcare.org